Volume 6 Issue 3
Jul.  2026
Turn off MathJax
Article Contents
Yanan Guo, Qing Liu, Wei Zhang, Bosen You, Bingmei Liu. A three-gene vasculogenic mimicry-related signature for prognostic stratification of patients with skin cutaneous melanoma[J]. Frigid Zone Medicine, 2026, 6(3): 179-192. doi: 10.1515/fzm-2026-0018
Citation: Yanan Guo, Qing Liu, Wei Zhang, Bosen You, Bingmei Liu. A three-gene vasculogenic mimicry-related signature for prognostic stratification of patients with skin cutaneous melanoma[J]. Frigid Zone Medicine, 2026, 6(3): 179-192. doi: 10.1515/fzm-2026-0018

A three-gene vasculogenic mimicry-related signature for prognostic stratification of patients with skin cutaneous melanoma

doi: 10.1515/fzm-2026-0018
Funds:

the Special Scientific Research Fund Project of the Fourth Affiliated Hospital of Harbin Medical University HYDSYTB202213

More Information
  •   Objective  Cutaneous melanoma (SKCM) is a highly aggressive malignancy associated with poor prognosis. This study aimed to develop a vasculogenic mimicry-related gene (VMRG) signature for individualized prognostic stratification and survival prediction in patients with SKCM.  Methods  A total of 42 VMRGs were collected from the published literature. Transcriptomic data from 813 normal skin samples and 471 SKCM samples were obtained from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression project (GTEx) databases. Differential expression analysis and univariate Cox regression analysis were performed to identify prognostically relevant VMRGs. Five candidate prognostic VMRGs were identified, and a three-VMRG prognostic signature was constructed using least absolute shrinkage and selection operator (LASSO) regression followed by multivariate Cox regression analysis.  Results  SKCM patients were stratified into high- and low-risk groups according to the three-VMRG signature. Kaplan-Meier survival analysis and time-dependent receiver operating characteristic (ROC) curve analysis demonstrated the prognostic performance of the signature. Multivariate analysis further identified the VMRG signature as an independent predictor of prognosis, and the signature was subsequently incorporated into a prognostic nomogram. In addition, the relationships between the risk signature and survival outcomes, clinicopathological characteristics, and the tumor immune microenvironment were systematically investigated.  Conclusions  The three-VMRG prognostic signature may serve as an independent prognostic indicator for patients with SKCM and facilitate individualized risk stratification. Its close association with the tumor immune microenvironment further suggests a potential link between vasculogenic mimicry-related molecular alterations and immune regulation in SKCM, providing a theoretical basis for future mechanistic and immunotherapy-related studies.

     

  • loading
  • [1]
    Chopra A, Rao U N M. Pathology of melanoma. Surg Clin North Am, 2020; 100(1): 43-59. doi: 10.1016/j.suc.2019.09.004
    [2]
    Wang P, Hu L, Fu G, et al. LncRNA MALAT1 Promotes the proliferation, migration, and invasion of melanoma cells by downregulating miR-23a. Cancer Manag Res, 2020; 12: 6553-6562. doi: 10.2147/CMAR.S249348
    [3]
    Siegel R L, Kratzer T B, Wagle N S, et al. Cancer statistics, 2021. CA Cancer J Clin, 2021; 71(1): 7-33.
    [4]
    Rastrelli M, Tropea S, Rossi C R, et al. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In vivo, 2014; 28(6): 1005-1011.
    [5]
    Tanaka R, Kashiwagi S, Ishihara S, et al. A case of malignant melanoma metastasis to the mammary gland. Gan To Kagaku Ryoho, 2014; 41(12): 1939-1941.
    [6]
    Braeuer R R, Watson I R, Wu C J, et al. Why is melanoma so metastatic? Pigment Cell Melanoma Res, 2014; 27(1): 19-36. doi: 10.1111/pcmr.12172
    [7]
    Bates J E, Youn P, Usuki K Y, et al. Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease. J Neurooncol, 2015; 125(2): 411-418. doi: 10.1007/s11060-015-1932-9
    [8]
    Alqahtani S, Alhefdhi A Y, Almalik O, et al. Primary oral malignant melanoma metastasis to the brain and breast: a case report and literature review. Oncol Lett, 2017; 14(2): 1275-1280. doi: 10.3892/ol.2017.6304
    [9]
    Xie R, Dong S, Jiang J, et al. Development and validation of an immune-related gene pair signature in skin cutaneous melanoma. Clin Cosmet Investig Dermatol, 2020; 13: 973-986. doi: 10.2147/CCID.S281364
    [10]
    Tracey E H, Vij A. Updates in melanoma. Dermatol Clin, 2019; 37(1): 73-82. doi: 10.1016/j.det.2018.08.003
    [11]
    Berk-Krauss J, Stein J A, Weber J, et al. New systematic therapies and trends in cutaneous melanoma deaths among US whites, 1986-2016. Am J Public Health, 2020; 110(5): 731-733. doi: 10.2105/AJPH.2020.305567
    [12]
    Bommareddy P K, Silk A W, Kaufman H L. Intratumoral approaches for the treatment of melanoma. Cancer J, 2017; 23(1): 40-47. doi: 10.1097/PPO.0000000000000234
    [13]
    Gide T N, Mao Y, Scolyer R A, et al. Tissue-based profiling techniques to achieve precision medicine in cancer: opportunities and challenges in melanoma. Clin Cancer Res, 2024; 30(23): 5270-5280. doi: 10.1158/1078-0432.CCR-24-1109
    [14]
    Luo Q, Wang J, Zhao W, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol, 2020; 13(1): 19. doi: 10.1186/s13045-020-00858-6
    [15]
    Maniotis A J, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro vasculogenic mimicry. Am J Pathol, 1999; 155(3): 739-752. doi: 10.1016/S0002-9440(10)65173-5
    [16]
    Serratì S, Roca M, D'Atri S, et al. Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance. Cancer Biol Med, 2025; 22(11): 1327-1352. doi: 10.20892/j.issn.2095-3941.2025.0048
    [17]
    Yang J P, Liao Y D, Mai D M, et al. Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis, 2016; 19(2): 191-200. doi: 10.1007/s10456-016-9500-2
    [18]
    Liu R, Yang K, Meng C, et al. Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol Ther, 2012; 13(7): 527-533. doi: 10.4161/cbt.19602
    [19]
    Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, et al. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer, 2017; 16(1): 65. doi: 10.1186/s12943-017-0631-x
    [20]
    Wang W, Lin P, Sun B, et al. Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma. Biomed Res Int, 2014; 2014: 803914.
    [21]
    Comito G, Calvani M, Giannoni E, et al. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med, 2011; 51(4): 893-904. doi: 10.1016/j.freeradbiomed.2011.05.042
    [22]
    Schnegg C I, Yang M H, Ghosh S K, et al. Induction of vasculogenic mimicry overrides VEGF-A silencing and enriches stem-like cancer cells in melanoma. Cancer Res, 2015; 75(8): 1682-1690. doi: 10.1158/0008-5472.CAN-14-1855
    [23]
    Mao X G, Xue X Y, Wang L, et al. CDH5 is specifically activated in glioblastoma stem-like cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro Oncol, 2013; 15(7): 865-879. doi: 10.1093/neuonc/not029
    [24]
    Ma X L, Zhu K P, Zhang C L. Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma. J Cancer, 2018; 9(10): 1856-1862. doi: 10.7150/jca.24619
    [25]
    Meng J, Chen S, Lei Y Y, et al. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma. Oncogene, 2019; 38(2): 228-243. doi: 10.1038/s41388-018-0428-4
    [26]
    Camorani S, Crescenzi E, Gramanzini M, et al. Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers. Sci Rep, 2017; 7: 46659. doi: 10.1038/srep46659
    [27]
    Wu S, Yu L, Wang D, et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer, 2012; 12: 535. doi: 10.1186/1471-2407-12-535
    [28]
    Li Y, Chen D, Jin L, et al. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Lett, 2017; 395: 31-44. doi: 10.1016/j.canlet.2017.02.035
    [29]
    Li W, Zong S Q, Shi Q, et al. Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: involvement of HIF-1α, Claudin-4, E-cadherin and Vimentin. Sci Rep, 2016; 6: 37534. doi: 10.1038/srep37534
    [30]
    Ge H, Luo H. Overview of advances in vasculogenic mimicry: a potential target for tumor therapy. Cancer Manag Res, 2018; 10: 2429-2437. doi: 10.2147/CMAR.S164675
    [31]
    Qiao L, Liang N, Zhang J, et al. Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med, 2015; 19(2): 315-326. doi: 10.1111/jcmm.12496
    [32]
    Wang Y B, Zou L X, Song M Z, et al. Establishment of skin cutaneous melanoma prognosis model based on vascular mimicry risk score. Medicine (Baltimore), 2024; 103(7): e36679. doi: 10.1097/MD.0000000000036679
    [33]
    Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw, 2010; 33(1): 1-22.
    [34]
    Tao C, Huang K, Shi J, et al. Genomics and prognosis analysis of epithelial-mesenchymal transition in glioma. Front Oncol, 2020; 10: 183. doi: 10.3389/fonc.2020.00183
    [35]
    Zhang W, Liu Z, Wang J, et al. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Front Immunol, 2022; 13: 934387. doi: 10.3389/fimmu.2022.934387
    [36]
    Hong C S, Sun E G, Choi J, et al. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer. Cancer Sci, 2020; 111(9): 3268-3278. doi: 10.1111/cas.14526
    [37]
    Lanaya H, Natarajan A, Komposch K, et al. EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat Cell Biol, 2014; 16(10): 972-977. doi: 10.1038/ncb3031
    [38]
    Rose M, Maurer A, Wirtz J, et al. EGFR activity addiction facilitates anti-ERBB-based combination treatment of squamous bladder cancer. Oncogene, 2020; 39(44): 6856-6870. doi: 10.1038/s41388-020-01465-y
    [39]
    Seguin L, Kato S, Franovic A, et al. An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol, 2014; 16(5): 457-468. doi: 10.1038/ncb2953
    [40]
    Caramel J, Ligier M, Puisieux A. Pleiotropic roles for ZEB1 in cancer. Cancer Res, 2018; 78(1): 30-35. doi: 10.1158/0008-5472.CAN-17-2476
    [41]
    Wu H T, Zhong H T, Li G W, et al. Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer. J Transl Med, 2020; 18(1): 51. doi: 10.1186/s12967-020-02240-z
    [42]
    Sierra J R, Corso S, Caione L, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med, 2008; 205(7): 1673-1685. doi: 10.1084/jem.20072602
    [43]
    Limonta P, Chiaramonte R, Casati L. Unveiling the dynamic interplay between cancer stem cells and the tumor microenvironment in melanoma: implications for novel therapeutic strategies. Cancers (Basel), 2024; 16(16): 2861. doi: 10.3390/cancers16162861
    [44]
    Trocchia M, Ventrici A, Modestino L, et al. Innate immune cells in melanoma: implications for immunotherapy. Int J Mol Sci, 2024; 25(15): 8523. doi: 10.3390/ijms25158523
    [45]
    Tas F, Erturk K. Seasons influence diagnosis and outcome of cutaneous melanoma. Dermatol Ther, 2020; 33(4): e13625.
  • fzm-6-3-179_Supplementary figS1.zip
    fzm-6-3-179_Supplementary data Table1.xlsx
    fzm-6-3-179_Supplementary figS2.zip
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(8)

    Article Metrics

    Article views (47) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return